• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃饥饿素、幽门螺杆菌与体重:它们之间有关联吗?

Ghrelin, Helicobacter pylori and body mass: is there an association?

作者信息

Boltin Doron, Niv Yaron

机构信息

Department of Gastroenterology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

出版信息

Isr Med Assoc J. 2012 Feb;14(2):130-2.

PMID:22693798
Abstract

Eradication of Helicobacter pylori is accompanied by an array of metabolic and hormonal changes in the host. Weight gain following H. pylori eradication is a poorly understood phenomenon and probably results from an interaction between multiple factors. Ghrelin, a peptide hormone secreted by the stomach, is involved in the regulation of food intake and appetite and may account for some of these changes. Although several observational studies have demonstrated that H. pylori infection suppresses circulating ghrelin levels, it has yet to be proven that ghrelin levels increase following eradication. On the other hand, gastric expression of ghrelin, also suppressed by H. pylori, clearly increases following eradication. The determinants of plasma ghrelin levels remain elusive, as do the effects of eradication on these levels. Weight gain following H. pylori eradication may be attributable to changes in plasma and gastric ghrelin; however, this hypothesis needs to be further investigated.

摘要

根除幽门螺杆菌会伴随宿主一系列代谢和激素变化。幽门螺杆菌根除后体重增加是一个尚未被充分理解的现象,可能是多种因素相互作用的结果。胃饥饿素是一种由胃分泌的肽类激素,参与食物摄入和食欲的调节,可能是这些变化的部分原因。尽管多项观察性研究表明幽门螺杆菌感染会抑制循环中的胃饥饿素水平,但根除幽门螺杆菌后胃饥饿素水平是否升高尚未得到证实。另一方面,同样被幽门螺杆菌抑制的胃饥饿素的胃表达,在根除后明显增加。血浆胃饥饿素水平的决定因素仍然难以捉摸,根除幽门螺杆菌对这些水平的影响也是如此。幽门螺杆菌根除后体重增加可能归因于血浆和胃中胃饥饿素的变化;然而,这一假设需要进一步研究。

相似文献

1
Ghrelin, Helicobacter pylori and body mass: is there an association?胃饥饿素、幽门螺杆菌与体重:它们之间有关联吗?
Isr Med Assoc J. 2012 Feb;14(2):130-2.
2
The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.幽门螺杆菌根除对消化性溃疡病患者胃饥饿素、食欲及体重指数的影响。
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S278-85. doi: 10.1111/j.1440-1746.2008.05415.x.
3
Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa.幽门螺杆菌感染对人胃黏膜中胃饥饿素表达的影响。
Am J Gastroenterol. 2004 Nov;99(11):2121-7. doi: 10.1111/j.1572-0241.2004.30291.x.
4
Influence of Helicobacter pylori on gastric regulation of food intake.幽门螺杆菌对胃调节食物摄入的影响。
Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):522-5. doi: 10.1097/MCO.0b013e32832eb56e.
5
Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients.肥胖患者中胃饥饿素表达与幽门螺杆菌感染及慢性胃炎相关。
Obes Surg. 2006 May;16(5):612-9. doi: 10.1381/096089206776945002.
6
Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection.Ghrelin 在与幽门螺杆菌感染相关的胃黏膜疾病中的作用。
Med Sci Monit. 2010 Oct;16(10):CR493-500.
7
Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans.幽门螺杆菌感染对人体胃及血浆胃饥饿素动态变化的影响。
Am J Gastroenterol. 2005 Aug;100(8):1711-20. doi: 10.1111/j.1572-0241.2005.41492.x.
8
Effect of Helicobacter pylori infection on gastric ghrelin expression and body weight.幽门螺杆菌感染对胃内胃饥饿素表达及体重的影响。
Rev Gastroenterol Mex. 2007 Oct-Dec;72(4):359-64.
9
Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection.幽门螺杆菌感染患者的循环胃饥饿素/肥胖抑制素比值
Nutrition. 2009 May;25(5):506-11. doi: 10.1016/j.nut.2008.11.002. Epub 2009 Jan 8.
10
Ghrelin and Helicobacter pylori infection.胃饥饿素与幽门螺杆菌感染
World J Gastroenterol. 2008 Nov 7;14(41):6327-33. doi: 10.3748/wjg.14.6327.

引用本文的文献

1
Gut peptide changes in patients with obstructive jaundice undergoing biliary drainage: A prospective case control study.接受胆道引流的梗阻性黄疸患者肠道肽的变化:一项前瞻性病例对照研究。
World J Clin Cases. 2022 Jun 16;10(17):5551-5565. doi: 10.12998/wjcc.v10.i17.5551.
2
Helicobacter pylori Infection Aggravates Diet-induced Insulin Resistance in Association With Gut Microbiota of Mice.幽门螺杆菌感染通过改变肠道微生物群加重饮食诱导的胰岛素抵抗。
EBioMedicine. 2016 Oct;12:247-254. doi: 10.1016/j.ebiom.2016.09.010. Epub 2016 Sep 13.
3
European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts.
欧洲肥胖峰会(EOS)——欧洲肥胖研究协会(EASO)与国际肥胖与代谢病外科联盟欧洲分会(IFSO-EC)联合大会,瑞典哥德堡,2016年6月1日至4日:摘要
Obes Facts. 2016;9 Suppl 1(Suppl 1):1-376. doi: 10.1159/000446744. Epub 2016 May 25.
4
Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass.接受幽门螺杆菌根除治疗的老年女性骨骼肌量低的风险降低。
Clin Interv Aging. 2015 Oct 30;10:1771-7. doi: 10.2147/CIA.S95007. eCollection 2015.
5
Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients.幽门螺杆菌粪便抗原水平和胃炎症的血清生物标志物与 2 型糖尿病患者的心血管代谢危险因素相关。
Endocrinol Metab (Seoul). 2015 Sep;30(3):280-7. doi: 10.3803/EnM.2015.30.3.280. Epub 2015 May 18.
6
Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication.血浆酰基胃饥饿素水平的升高与幽门螺杆菌根除后消化不良的缓解有关。
J Gastroenterol. 2016 Jun;51(6):548-59. doi: 10.1007/s00535-015-1124-6. Epub 2015 Sep 28.
7
Elevated levels of adaption in Helicobacter pylori genomes from Japan; a link to higher incidences of gastric cancer?日本幽门螺杆菌基因组中适应性水平升高;与胃癌发病率升高有关?
Evol Med Public Health. 2015 Mar 18;2015(1):88-105. doi: 10.1093/emph/eov005.
8
Human Microbiome: When a Friend Becomes an Enemy.人类微生物群:当朋友变成敌人时。
Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):287-98. doi: 10.1007/s00005-015-0332-3. Epub 2015 Feb 15.
9
Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma.将肥胖与食管腺癌联系起来的病理生理机制。
World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):534-49. doi: 10.4291/wjgp.v5.i4.534.
10
The role of obesity in oesophageal cancer development.肥胖在食管癌发展中的作用。
Therap Adv Gastroenterol. 2014 Nov;7(6):247-68. doi: 10.1177/1756283X14538689.